ArticleSurgical neurology international2025
Motor cortex stimulation for phantom limb pain treatment.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Phantom limb pain (PLP) is a chronic neuropathic pain syndrome experienced by individuals following limb amputation. Despite the use of various pharmacological treatments, including opioids, antidepressants, and anticonvulsants, effective pain relief remains challenging for many patients. Motor cortex stimulation (MCS) has emerged as a promising alternative for managing PLP. Methods: We present the management of three patients with chronic, refractory PLP who underwent epidural MCS at Lille University Hospital Center. The quadripolar electrode lead was implanted into the epidural space under local anesthesia. Stereotactic angiography was used to determine the target coordinates, and the optimal location was confirmed with the guidance of a three-dimensional brain magnetic resonance imaging reconstruction and neurophysiological testing. Pain intensity was assessed using the Visual Analog Scale (VAS) at baseline and at the end of the follow-up period, which had a mean duration of 7 ± 2.16 months. Results: Two of the three patients experienced a decrease in pain by 50%, and one had a 44.4% reduction. The average preoperative VAS score significantly decreased from 7.0 ± 1.73 to 3.67 ± 1.15 at the final follow-up ( Conclusion: PLP is one of the most challenging conditions to treat. MCS is an adjustable and reversible technique that appears to be effective in treating patients with this chronic pain syndrome refractory to other treatment modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.